Effectiveness of Micronutrient Supplementation and Fish Oil + Micronutrient Supplementation in the Treatment of Environmental Enteropathy

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT01593033
Collaborator
(none)
225
1
3
6
37.2

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the therapeutic effectiveness of micronutrients (full RDA) and micronutrients + fish oil as separate interventions in restoring normal gut absorptive and immunological function as measured by the dual sugar permeability test and additional biomarkers in 1-3 year old rural Malawian children at high risk for Environmental Enteropathy.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Fish oil and Micronutrient Supplementation
  • Dietary Supplement: Micronutrient Supplement
  • Drug: Placebo
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
225 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Randomized, Double-blind, Placebo-controlled Trial Evaluating the Impact of Micronutrient Supplementation and Fish Oil + Micronutrient Supplementation in the Treatment of Sub-clinical Environmental Enteropathy in Rural Malawian Children
Study Start Date :
May 1, 2012
Actual Primary Completion Date :
Nov 1, 2012
Actual Study Completion Date :
Nov 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fish oil and Micronutrient Supplementation

Dietary Supplement: Fish oil and Micronutrient Supplementation
0.9 mL highly purified fish oil (200 mg docosahexaenoic acid, 300 mg eicosapentaenoic acid) to be given daily for 6 months 1 RDA of all known micronutrients needed for normal child growth in powder form to be given daily for 6 months

Experimental: Micronutrient Supplementation

Dietary Supplement: Micronutrient Supplement
1 RDA all known micronutrients needed for normal child growth to be given daily in powder form for 6 months 0.9 mL palm oil given daily for 6 months

Placebo Comparator: Placebo

Drug: Placebo
10 g sugar in granule form to be given daily for 6 months 0.9 mL palm oil to be given daily for 6 months

Outcome Measures

Primary Outcome Measures

  1. Changes in urine lactulose:mannitol (L:M) ratio following therapy course. [3 months, 6 months]

Secondary Outcome Measures

  1. Changes in the expression of several fecal mRNAs [3 months, 6 months]

  2. Changes in amounts of lactulose and mannitol excreted in the urine as a percentage of the amounts ingested [3 months, 6 months]

  3. Change in height [3 month, 6 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 3 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 1-3 years of age

  • Lives in study villages

  • Will not move in next 6 months

  • Caregiver willing to give intervention daily for 6 months

Exclusion Criteria:
  • Unable to drink 20 mL of sugar water

  • Demonstrating evidence of severe acute malnutrition, WHZ < or = -3, presence of bi-pedal pitting edema

  • Apparent need for acute medical treatment for an illness or injury

  • Caregiver refusal to participate and return for 3 and 6 month follow-ups

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint Louis Nutrition Project Blantyre Malawi

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

  • Principal Investigator: Mark J Manary, M.D., Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01593033
Other Study ID Numbers:
  • MJM - Fish Oil
First Posted:
May 7, 2012
Last Update Posted:
Jan 14, 2013
Last Verified:
Jan 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2013